B

Belluscura PLC
LSE:BELL

Watchlist Manager
Belluscura PLC
LSE:BELL
Watchlist
Price: 10.25 GBX 7.89% Market Closed
Market Cap: 17.3m GBX
Have any thoughts about
Belluscura PLC?
Write Note

Belluscura PLC
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Belluscura PLC
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
Belluscura PLC
LSE:BELL
Total Equity
$20.4m
CAGR 3-Years
63%
CAGR 5-Years
55%
CAGR 10-Years
N/A
Smith & Nephew PLC
LSE:SN
Total Equity
$5.2B
CAGR 3-Years
-1%
CAGR 5-Years
1%
CAGR 10-Years
N/A
LivaNova PLC
NASDAQ:LIVN
Total Equity
$1.3B
CAGR 3-Years
0%
CAGR 5-Years
-3%
CAGR 10-Years
17%
EKF Diagnostics Holdings PLC
LSE:EKF
Total Equity
ÂŁ68.8m
CAGR 3-Years
-7%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Angle PLC
LSE:AGL
Total Equity
ÂŁ24.5m
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Creo Medical Group PLC
LSE:CREO
Total Equity
ÂŁ47.4m
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
N/A
No Stocks Found

Belluscura PLC
Glance View

Market Cap
16.3m GBX
Industry
Health Care

Belluscura Plc engages in the provision of medical devices. The Company’s product, the X-PLO2R, is a lightweight portable oxygen concentrator (POC), which is designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company focuses on devices and treatments involving oxygen. The X-PLO2R DX is designed to produce approximately six-liters pulse dose oxygen and approximately two-liters of flow oxygen. The firm is focused on developing the medical devices for treating people who are suffering from chronic lung diseases, such as the chronic obstructive pulmonary disease (COPD), respiratory distress caused by coronavirus disease (COVID-19), and other respiratory disorders.

BELL Intrinsic Value
11.52 GBX
Undervaluation 11%
Intrinsic Value
Price
B

See Also

What is Belluscura PLC's Total Equity?
Total Equity
20.4m USD

Based on the financial report for Dec 31, 2023, Belluscura PLC's Total Equity amounts to 20.4m USD.

What is Belluscura PLC's Total Equity growth rate?
Total Equity CAGR 5Y
55%

Over the last year, the Total Equity growth was 0%. The average annual Total Equity growth rates for Belluscura PLC have been 63% over the past three years , 55% over the past five years .

Back to Top